Matt O'Brien

Stock Analyst at Piper Sandler

(2.50)
# 2,275
Out of 4,712 analysts
172
Total ratings
49.65%
Success rate
-2.01%
Average return

Stocks Rated by Matt O'Brien

TransMedics Group
Dec 11, 2024
Maintains: Overweight
Price Target: $110$90
Current: $62.60
Upside: +43.77%
Penumbra
Nov 20, 2024
Maintains: Overweight
Price Target: $235$250
Current: $240.54
Upside: +3.93%
AVITA Medical
Nov 8, 2024
Reiterates: Neutral
Price Target: $9$12
Current: $13.17
Upside: -8.88%
Sight Sciences
Nov 8, 2024
Reiterates: Neutral
Price Target: $6$5.5
Current: $3.61
Upside: +52.35%
TELA Bio
Nov 8, 2024
Maintains: Overweight
Price Target: $8$5
Current: $2.92
Upside: +71.23%
Globus Medical
Nov 6, 2024
Maintains: Overweight
Price Target: $80$100
Current: $84.42
Upside: +18.46%
CVRx, Inc.
Oct 30, 2024
Reiterates: Overweight
Price Target: $13$16
Current: $13.62
Upside: +17.47%
Stryker
Oct 30, 2024
Reiterates: Overweight
Price Target: $380$420
Current: $369.42
Upside: +13.69%
Integer Holdings
Oct 25, 2024
Reiterates: Overweight
Price Target: $125$140
Current: $135.88
Upside: +3.03%
PROCEPT BioRobotics
Oct 8, 2024
Reiterates: Overweight
Price Target: $75
Current: $83.53
Upside: -10.21%
Maintains: Overweight
Price Target: $230$285
Current: $265.68
Upside: +7.27%
Reiterates: Overweight
Price Target: $90
Current: $80.57
Upside: +11.70%
Maintains: Neutral
Price Target: $85$90
Current: $81.60
Upside: +10.29%
Reiterates: Neutral
Price Target: $3$1
Current: $0.32
Upside: +213.58%
Reiterates: Overweight
Price Target: $15$12
Current: $10.35
Upside: +15.94%
Reiterates: Overweight
Price Target: $50$55
Current: $37.37
Upside: +47.18%
Maintains: Overweight
Price Target: $17$12
Current: $9.33
Upside: +28.62%
Maintains: Overweight
Price Target: $110$140
Current: $152.67
Upside: -8.30%
Maintains: Overweight
Price Target: $95$80
Current: $71.23
Upside: +12.31%
Maintains: Overweight
Price Target: $65$40
Current: $30.75
Upside: +30.08%
Upgrades: Overweight
Price Target: $205$245
Current: $180.14
Upside: +36.01%
Maintains: Neutral
Price Target: $33$40
Current: $24.60
Upside: +62.60%
Initiates: Overweight
Price Target: $25
Current: $13.84
Upside: +80.64%
Reiterates: Overweight
Price Target: $40
Current: $23.38
Upside: +71.09%
Maintains: Neutral
Price Target: $3.5$3
Current: $5.29
Upside: -43.29%
Maintains: Overweight
Price Target: $4$4.5
Current: $1.60
Upside: +181.25%
Maintains: Overweight
Price Target: $58$62
Current: $91.45
Upside: -32.20%
Upgrades: Overweight
Price Target: n/a
Current: $107.25
Upside: -
Initiates: Overweight
Price Target: $15
Current: $4.77
Upside: +214.47%
Maintains: Overweight
Price Target: $93$109
Current: $92.61
Upside: +17.43%
Downgrades: Neutral
Price Target: $25$18
Current: $8.32
Upside: +118.51%
Downgrades: Neutral
Price Target: $100$80
Current: $29.30
Upside: +173.04%
Initiates: Overweight
Price Target: $12
Current: $3.99
Upside: +200.75%